Codexis (NASDAQ: CDXS) announced that it has entered into a collaborative research and development agreement with a leading global biopharmaceutical ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Management Comments

Codexis (CDXS) Tops Q2 EPS by 7cAugust 11, 2015 4:07 PM Codexis Collaborates With Leading Biopharmaceutical Company to Apply CodeEvolver Protein Engineering in Therapeutics Development ProgramAugust 11, 2015 7:00 AM Codexis Collaborates With Leading Biopharmaceutical Company to Apply CodeEvolver Protein Engineering in Therapeutics Development ProgramAugust 11, 2015 7:00 AM